Literature DB >> 26706849

Coronary Revascularization in Cardiogenic Shock.

Nathan Spence1, J Dawn Abbott2.   

Abstract

OPINION STATEMENT: Early revascularization in acute myocardial infarction (MI) complicated by cardiogenic shock (CS) reduces mortality with a life saved for every eight patients treated. Percutaneous coronary intervention (PCI) has become the mainstay of treatment for CS, particularly for ST-segment elevation MI, due to the ability to achieve rapid reperfusion; with coronary artery bypass graft (CABG) operations reserved for patients with mechanical complications or anatomy that poses challenges for timely PCI. Mortality remains high even in patients with successful revascularization, and interventional cardiologists must consider additional treatment options. Recent data supports the performance of multi-vessel PCI to achieve complete revascularization in this setting. In addition, early implementation of a percutaneous hemodynamic support device is recommended in patients in whom shock is profound and unlikely to reverse with culprit lesion PCI.

Entities:  

Keywords:  Acute coronary syndrome; Cardiogenic shock; Coronary revascularization; Hemodynamic support devices; Mechanical circulatory support; Percutaneous coronary intervention

Year:  2016        PMID: 26706849     DOI: 10.1007/s11936-015-0423-9

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  50 in total

1.  Impella 2.5.

Authors:  Daniel H Raess; David M Weber
Journal:  J Cardiovasc Transl Res       Date:  2009-04-02       Impact factor: 4.132

2.  Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock.

Authors:  Jiunn-Jye Sheu; Tzu-Hsien Tsai; Fan-Yen Lee; Hsiu-Yu Fang; Cheuk-Kwan Sun; Steve Leu; Cheng-Hsu Yang; Shyh-Ming Chen; Chi-Ling Hang; Yuan-Kai Hsieh; Chien-Jen Chen; Chiung-Jen Wu; Hon-Kan Yip
Journal:  Crit Care Med       Date:  2010-09       Impact factor: 7.598

3.  Comparison of dopamine and norepinephrine in the treatment of shock.

Authors:  Daniel De Backer; Patrick Biston; Jacques Devriendt; Christian Madl; Didier Chochrad; Cesar Aldecoa; Alexandre Brasseur; Pierre Defrance; Philippe Gottignies; Jean-Louis Vincent
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

4.  Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock.

Authors:  Holger Thiele; Peter Sick; Enno Boudriot; Klaus-Werner Diederich; Rainer Hambrecht; Josef Niebauer; Gerhard Schuler
Journal:  Eur Heart J       Date:  2005-02-25       Impact factor: 29.983

5.  Outcomes with invasive vs conservative management of cardiogenic shock complicating acute myocardial infarction.

Authors:  Sripal Bangalore; Navdeep Gupta; Yu Guo; Anuradha Lala; Leora Balsam; Robert O Roswell; Alex Reyentovich; Judith S Hochman
Journal:  Am J Med       Date:  2014-12-30       Impact factor: 4.965

6.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

7.  Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective.

Authors:  Robert J Goldberg; Frederick A Spencer; Joel M Gore; Darleen Lessard; Jorge Yarzebski
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

8.  Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry.

Authors:  V Dzavik; L A Sleeper; T P Cocke; M Moscucci; J Saucedo; S Hosat; X Jiang; J Slater; T LeJemtel; J S Hochman
Journal:  Eur Heart J       Date:  2003-05       Impact factor: 29.983

9.  Cardiac power index, mean arterial pressure, and Simplified Acute Physiology Score II are strong predictors of survival and response to revascularization in cardiogenic shock.

Authors:  Batric Popovic; Renaud Fay; Aurelie Cravoisy-Popovic; Bruno Levy
Journal:  Shock       Date:  2014-07       Impact factor: 3.454

10.  A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.

Authors:  Melchior Seyfarth; Dirk Sibbing; Iris Bauer; Georg Fröhlich; Lorenz Bott-Flügel; Robert Byrne; Josef Dirschinger; Adnan Kastrati; Albert Schömig
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

View more
  3 in total

1.  An unusual case of renal calculi leading to myocardial infarction and cardiogenic shock.

Authors:  Vanessa Santos; James Espinosa; Alan Lucerna; Andrew Caravello
Journal:  World J Emerg Med       Date:  2017

2.  Effects of Low-Dose Recombinant Human Brain Natriuretic Peptide on Anterior Myocardial Infarction Complicated by Cardiogenic Shock.

Authors:  Yesheng Pan; ZhiGang Lu; Jingyu Hang; Shixin Ma; Jian Ma; Meng Wei
Journal:  Braz J Cardiovasc Surg       Date:  2017 Mar-Apr

3.  Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018.

Authors:  Rohan Khera; Eric A Secemsky; Yongfei Wang; Nihar R Desai; Harlan M Krumholz; Thomas M Maddox; Kendrick A Shunk; Salim S Virani; Deepak L Bhatt; Jeptha Curtis; Robert W Yeh
Journal:  JAMA Intern Med       Date:  2020-10-01       Impact factor: 44.409

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.